MCID: INT106
MIFTS: 7

Interleukin 2 Receptor Alpha Chain Deficiency malady

Categories: Genetic diseases

Aliases & Classifications for Interleukin 2 Receptor Alpha Chain Deficiency

Aliases & Descriptions for Interleukin 2 Receptor Alpha Chain Deficiency:

Name: Interleukin 2 Receptor Alpha Chain Deficiency 24

Classifications:



Summaries for Interleukin 2 Receptor Alpha Chain Deficiency

MalaCards based summary : Interleukin 2 Receptor Alpha Chain Deficiency An important gene associated with Interleukin 2 Receptor Alpha Chain Deficiency is IL2RA (Interleukin 2 Receptor Subunit Alpha). The drugs Daclizumab and Triamcinolone have been mentioned in the context of this disorder.

Related Diseases for Interleukin 2 Receptor Alpha Chain Deficiency

Symptoms & Phenotypes for Interleukin 2 Receptor Alpha Chain Deficiency

Drugs & Therapeutics for Interleukin 2 Receptor Alpha Chain Deficiency

Drugs for Interleukin 2 Receptor Alpha Chain Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Daclizumab Approved, Investigational Phase 2,Phase 1 152923-56-3
2
Triamcinolone Approved, Vet_approved Phase 1, Phase 2 124-94-7 31307
3 triamcinolone acetonide Phase 1, Phase 2
4 Interleukin-2 Phase 1, Phase 2
5 Analgesics Phase 1, Phase 2
6 Analgesics, Non-Narcotic Phase 1, Phase 2
7 Triamcinolone diacetate Phase 1, Phase 2
8 Triamcinolone hexacetonide Phase 1, Phase 2
9 Peripheral Nervous System Agents Phase 1, Phase 2
10 Immunoglobulin G Phase 2,Phase 1
11 Immunoglobulins Phase 2,Phase 1
12 Antibodies, Monoclonal Phase 1, Phase 2
13 Immunosuppressive Agents Phase 2,Phase 1
14 Antilymphocyte Serum Phase 2
15 Antibodies Phase 2,Phase 1
16
Zidovudine Approved Phase 1 30516-87-1 35370
17
Thymalfasin Approved, Investigational Phase 1 62304-98-7
18 Adjuvants, Immunologic Phase 1
19 Nucleic Acid Synthesis Inhibitors Phase 1
20 Anti-HIV Agents Phase 1
21 Anti-Infective Agents Phase 1
22 Antimetabolites Phase 1
23 Anti-Retroviral Agents Phase 1
24 Reverse Transcriptase Inhibitors Phase 1
25 Antiviral Agents Phase 1

Interventional clinical trials:


id Name Status NCT ID Phase
1 A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS) Completed NCT00072969 Phase 2
2 Anti-Tac for Treatment of Leukemia Completed NCT00001941 Phase 1, Phase 2
3 Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients Completed NCT00001474 Phase 2
4 The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection Completed NCT00001036 Phase 1

Search NIH Clinical Center for Interleukin 2 Receptor Alpha Chain Deficiency

Genetic Tests for Interleukin 2 Receptor Alpha Chain Deficiency

Genetic tests related to Interleukin 2 Receptor Alpha Chain Deficiency:

id Genetic test Affiliating Genes
1 Interleukin 2 Receptor Alpha Chain Deficiency 24 IL2RA

Anatomical Context for Interleukin 2 Receptor Alpha Chain Deficiency

Publications for Interleukin 2 Receptor Alpha Chain Deficiency

Variations for Interleukin 2 Receptor Alpha Chain Deficiency

Expression for Interleukin 2 Receptor Alpha Chain Deficiency

Search GEO for disease gene expression data for Interleukin 2 Receptor Alpha Chain Deficiency.

Pathways for Interleukin 2 Receptor Alpha Chain Deficiency

GO Terms for Interleukin 2 Receptor Alpha Chain Deficiency

Sources for Interleukin 2 Receptor Alpha Chain Deficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....